Pulmonary Manifestations of Systemic Lupus Erythematosus

ABSTRACT

Systemic lupus erythematosus (SLE) can affect the lung in multiple ways. All components of the respiratory system, including the pleura, pulmonary parenchyma, airways, vessels, and respiratory muscles can be involved in various degrees at some time in the disease course and contribute to its morbidity and mortality. This article reviews the clinical symptoms, imaging techniques, histopathology, prognosis, and treatment of pulmonary manifestations of SLE and the related disorder mixed connective tissue disease (MCTD), from a historical perspective and with regard to new insights into pathogenesis and therapy.

KEYWORDS

Systemic lupus erythematosus - pleuropulmonary disease - prognosis - treatment

REFERENCES

• 1 Osler W. On the visceral manifestations of the erythema group of skin diseases.  Am J Med Sci. 1904;  127 1-3
• 2 D'Cruz D, Khamashta M, Hughes G. Pulmonary manifestations of systemic lupus erythematosus. In: Wallace DJ, Hahn BHH Dubois' Lupus Erythematosus. Philadelphia; Lippincott, Williams and Wilkins 2002: 663-683
• 3 Estes D, Christian C L. The natural history of systemic lupus erythematosus by prospective analysis.  Medicine. 1971;  50 85-94
• 4 Huang C-T, Hennigar G R, Lyons H A. Pulmonary dysfunction in with systemic lupus erythematosus.  N Engl J Med. 1965;  272 288-293
• 5 Andonopoulos A P, Constantopoulos S H, Galanopoulou V, Drosos A A, Acritidis N C, Moutsopoulos H M. Pulmonary function of nonsmoking patients with systemic lupus erythematosus.  Chest. 1988;  94 312-315
• 6 Groen H, ter Borg E J, Postma D S, Wouda A A, van der Mark T W, Kallenberg C G. Pulmonary function in systemic lupus erythematosus is related to distinct clinical, serologic, and nailfold capillary patterns.  Am J Med. 1992;  93 619-627
• 7 Jonsson H, Nived O, Sturfelt G, Valind S, Jonson B. Lung function in patients with systemic lupus erythematosus and persistent chest symptoms.  Br J Rheumatol. 1989;  28 492-499
• 8 Rolla G, Brussino L, Bertero M T, Bucca C, Converso M, Caligaris-Capio F. Respiratory function in systemic lupus erythematosus: relation with activity and severity.  Lupus. 1996;  5 38-43
• 9 Scano G, Goti P, Duranti R, Misuri G, Emmi L, Rosi E. Control of breathing in a subset of patients with systemic lupus erythematosus.  Chest. 1995;  108 759-766
• 10 Gibson C J, Edmonds J P, Hughes G RV. Diaphragm function and lung involvement in systemic lupus erythematosus.  Am J Med. 1977;  63 926-932
• 11 Hardy K, Herry I, Attali V, Cadranel J, Similowsky T. Bilateral phrenic paralysis in a patient with systemic lupus erythematosus.  Chest. 2001;  119 1274-1277
• 12 Al-Raqum H A, Uppal S S, Al-Mutairy M, Kumari R. Shrinking lung syndrome as a presenting manifestation of systemic lupus erythematosus in a female Kuwaiti.  Clin Rheumatol. 2006;  25 412-414
• 13 Keane M P, Lynch III J P. Pleuropulmonary manifestations of systemic lupus erythematosus.  Thorax. 2000;  55 159-166
• 14 Cervera R, Khamashta M A, Font J et al.. Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1000 patients. The European Working Party on Systemic Lupus Erythematosus.  Medicine (Baltimore). 1993;  72 113-124
• 15 Sahn S A. The pathophysiology of pleural effusions.  Annu Rev Med. 1990;  41 7-13
• 16 Turner-Stokes L, Haslam P, Jones M et al.. Autoantibody and idiotype profile of lung involvement in autoimmune rheumatic disease.  Ann Rheum Dis. 1990;  49 160-162
• 17 Wiedemann H P, Matthay R A. Pulmonary manifestations of the collagen vascular diseases.  Clin Chest Med. 1989;  10 677-722
• 18 Crestani B. The respiratory system in connective tissue disorders.  Allergy. 2005;  60 715-735
• 19 Fenlon H M, Doran M, Sant S M, Breatnach E. High resolution chest CT in systemic lupus erythematosus.  AJR Am J Roentgenol. 1996;  166 301-307
• 20 Susanto I, Peters J I. Acute lupus pneumonitis with normal chest radiograph.  Chest. 1997;  111 1781-1783
• 21 Inoue T, Kanayama Y, Ohe A et al.. Immunopathologic studies of pneumonitis in systemic lupus erythematosus.  Ann Intern Med. 1979;  91 30-34
• 22 Boulware D W, Hedgpeth M T. Lupus pneumonitis and anti-SSA(Ro) antibodies.  J Rheumatol. 1989;  16 479-481
• 23 Mochizuki T, Aotsuka S, Satoh T. Clinical and laboratory features of lupus patients with complicating pulmonary disease.  Respir Med. 1999;  93 95-101
• 24 Raj R, Murin S, Matthay R A, Widemann H P. Systemic lupus erythematosus in the intensive care unit.  Crit Care Clin. 2002;  18 781-803
• 25 Isbister J P, Ralston M, Hayes J M, Wright R. Fulminant lupus pneumonitis with acute renal failure and RBC aplasia: successful management with plasmapheresis and immunosuppression.  Arch Intern Med. 1981;  141 1081-1083
• 26 Winder A, Molad Y, Osfeld I et al.. Treatment of systemic lupus erythematosus by prolonged administration of high dose of intravenous immunoglobulin: report of 2 cases.  J Rheumatol. 1993;  20 495-498
• 27 Eiser A R, Shanies H M. Treatment of lupus interstitial lung disease with intravenous cyclophosphamide.  Arthritis Rheum. 1994;  37 428-431
• 28 Santos-Ocampo A S, Mandell B F, Fessler B J. Alveolar hemorrhage in systemic lupus erythematosus.  Chest. 2000;  118 1083-1090
• 29 Haupt H M, Moore G W, Hutchins G M. The lung in systemic lupus erythematosus.  Am J Med. 1981;  71 791-798
• 30 Zamora M R, Warner M L, Tuder R, Schwarz M I. Diffuse alveolar hemorrhage and systemic lupus erythematosus: clinical presentation, histology, survival, and outcome.  Medicine. 1997;  76 192-202
• 31 Myers J L, Katsenstein A L. Microangiitis in lupus-induced pulmonary hemorrhage.  Am J Clin Pathol. 1986;  85 552-556
• 32 Onomura K, Nakata H, Tanakaya Y, Tsuda T. Pulmonary hemorrhage in patients with systemic lupus erythematosus.  J Thorac Imaging. 1991;  6 57-61
• 33 Orens J B, Martinez F J, Lynch J P. Pleuropulmonary manifestations of systemic lupus erythematosus.  Rheum Dis Clin North Am. 1994;  20 159-192
• 34 Dweik R A, Arroliga A C, Cash G M. Alveolar hemorrhage in patients with rheumatic disease.  Rheum Dis Clin North Am. 1997;  23 395-410
• 35 Erickson R W, Franklin W A, Emlen W. Treatment of hemorrhagic lupus pneumonitis with plasmapheresis.  Semin Arthritis Rheum. 1994;  24 114-123
• 36 Sant S M, Doran M, Fenelon H M, Breatnach E S. Pleuropulmonary abnormalities in patients with systemic lupus erythematous: assessment with high resolution computed tomography, chest radiography and pulmonary function tests.  Clin Exp Rheumatol. 1997;  15 507-513
• 37 Bankier A A, Kiener H P, Wiesmayr M N et al.. Discrete lung involvement in systemic lupus erythematosus: CT assessment.  Radiology. 1995;  196 835-840
• 38 Ooi G C, Ngan H, Peh W CG et al.. Systemic lupus erythematosus patients with respiratory symptoms: the value of HRCT.  Clin Radiol. 1997;  52 775-781
• 39 Jacobsen S, Petersen J, Ullman S et al.. A multicenter study of 513 Danish patients with systemic lupus erythematosus, I: Disease manifestations and analysis of clinical subsets.  Clin Rheumatol. 1998;  17 468-477
• 40 Weinrib L, Sharma O P, Quismorio Jr F P. A long-term study of interstitial lung disease in systemic lupus erythematosus.  Semin Arthritis Rheum. 1990;  20 48-56
• 41 Colby T V. Pulmonary pathology in patients with systemic autoimmune diseases.  Clin Chest Med. 1998;  19 587-612
• 42 Swigris J J, Olson A L, Fischer A et al.. Mycophenolate mofetil is safe, well tolerated, and preserves lung function in patients with connective tissue-related interstitial lung disease.  Chest. 2006;  130 30-36
• 43 Langford C A, Waes C. Upper airway obstruction in the rheumatic diseases: life-threatening complications of autoimmune disease.  Rheum Dis Clin North Am. 1997;  23 345-363
• 44 Smith G A, Ward P H, Berci G. Laryngeal lupus erythematosus.  J Laryngol Otol. 1978;  92 67-73
• 45 Teitel A D, MacKenzie C R, Stern R et al.. laryngeal involvement in systemic lupus erythematosus.  Semin Arthritis Rheum. 1992;  22 203-214
• 46 Curley J W, Byron M A, Bates G J. Cryco-arytenoid joint involvement in acute systemic lupus erythematosus.  J Otol  1986;  100 727-732
• 47 Nossent J, Berend K. Cricoarytenoiditis in systemic lupus erythematosus.  Scand J Rheumatol. 1998;  27 237-238
• 48 Karim A, Shahid A, Siddiqui R et al.. Severe upper airway obstruction from crycoarytenoiditis as the sole presenting manifestation of a systemic lupus erythematosus flare.  Chest. 2002;  121 990-993
• 49 Godeau B, Cormier C, Menkes C J. Bronchiolitis obliterans in systemic lupus erythematosus: beneficial effect of intravenous cyclophosphamide.  Ann Rheum Dis. 1991;  50 956-958
• 50 Hinderliter A L, Willis P W, Barst R J et al.. Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension: Primary Pulmonary Hypertension Study Group.  Circulation. 1997;  95 1479-1486
• 51 Winslow T M, Ossipov M A, Fazio G P et al.. The left ventricle in systemic lupus erythematosus: initial observations and a five-year follow-up in a university medical center population.  Am Heart J. 1993;  125 1117-1122
• 52 Hosoda Y, Suzuki Y, Takano M et al.. Mixed connective tissue disease with pulmonary hypertension: a clinical and pathological study.  J Rheumatol. 1987;  14 826-830
• 53 Sullivan W D, Hurst D J, Harmon C E et al.. A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease.  Medicine. 1984;  63 92-107
• 54 Chung S M, Lee C K, Lee E Y, Yoo B, Lee S D, Moon H B. Clinical aspects of pulmonary hypertension in patients with idiopathic pulmonary arterial hypertension.  Clin Rheumatol. 2006;  25 866-872
• 55 Burdt M A, Hoffman R W, Deutscher S L et al.. Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings.  Arthritis Rheum. 1999;  42 899-909
• 56 Quismorio Jr F P, Shjarma O, Koss M et al.. Immunopathologic and clinical studies in clinical studies in pulmonary hypertension associated with systemic lupus erythematosus.  Semin Arthritis Rheum. 1984;  13 349-359
• 57 Grunig E, Janssen B, Mereles D et al.. Abnormal pulmonary artery pressure response in asymptomatic carriers of primary pulmonary hypertension gene.  Circulation. 2000;  102 1145-1150
• 58 McGoon M, Gutterman D, Steen V et al.. Screening, early detection, and diagnosis of pulmonary artery hypertension.  Chest. 2004;  126 14S-34S
• 59 Miyamoto S, Nagaya N, Satoh T et al.. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension: comparison with cardiopulmonary exercise testing.  Am J Respir Crit Care Med. 2000;  161 487-492
• 60 Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary artery hypertension.  N Engl J Med. 2004;  351 1425-1436
• 61 Simonson J S, Schiller N B, Petri M et al.. Pulmonary hypertension in systemic lupus erythematosus.  J Rheumatol. 1989;  16 918-925
• 62 Asherson R A, Higenbottom T W, Dihn Xuan A T et al.. Pulmonary hypertension in a lupus clinic: experience with twenty four patients.  J Rheumatol. 1990;  17 1292-1298
• 63 Christman B W, McPherson C D, Newman J H et al.. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension.  1992;  327 70-75
• 64 Giaid A, Yanagisawa M, Langleben D et al.. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension.  1993;  328 1732-1739
• 65 Cella G, Belloto F, Tona F et al.. Plasma markers of endothelial dysfunction in pulmonary hypertension.  Chest. 2001;  120 1226-1230
• 66 McLaughlin V V, Presberg K W, Doyle R L et al.. Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines.  Chest. 2004;  126 78S-92S
• 67 Galiè N, Ghofrani H A, Torbicki A et al.. Sildenafil citrate therapy for pulmonary arterial hypertension.  N Engl J Med. 2005;  353 2148-2157
• 68 Fuster V, Steele P M, Edwards W D, Gersh B J, McGoon M D, Frye R L. Primary pulmonary hypertension: natural history and the importance of thrombosis.  Circulation. 1984;  70 580-587
• 69 Abu-Shakra M, Gladman D D, Urowits M B et al.. Anticardiolipin antibodies in systemic lupus erythematosus: clinical and laboratory correlations.  Am J Med. 1995;  99 624-628
• 70 Asherson R A, Cervera R, Piette J C et al.. Catastrophic antiphospholipid syndrome: clinical and laboratory features of 50 patients.  Medicine. 1998;  77 195-207
• 71 Hoffbrand B I, Beck E R. Unexplained dyspnea and shrinking lungs in systemic lupus erythematosus.  BMJ. 1965;  1 1273-1277
• 72 Rubin L A, Urowitz M B. Shrinking lung syndrome in SLE: a clinical pathologic study.  J Rheumatol. 1983;  10 973-976
• 73 Laroche C M, Mulvey D A, Hawkins P N et al.. Diaphragm strength in the shrinking lung syndrome of with systemic lupus erythematosus.  Q J Med. 1989;  71 429-439
• 74 Warrington K J, Moder K G, Brutinel W M. The shrinking lungs syndrome in systemic lupus erythematosus.  Mayo Clin Proc. 2000;  75 467-472
• 75 Abramson S B, Dobro J, Eberle M A et al.. Acute reversible hypoxemia in systemic lupus erythematosus.  Ann Intern Med. 1991;  114 941-947
• 76 Kim W U, Kim S I, Yoo W H et al.. Adult respiratory distress syndrome in systemic lupus erythematosus: causes and prognostic factors: a single center, retrospective study.  Lupus. 1999;  8 552-557